期刊文献+

载纳豆激酶的三甲基壳聚糖纳米粒的制备及体外释放度研究 被引量:1

Preparation of Nattokinase-loaded Trimethyl Chitosan Nanoparticles and Study on Its Release Rate in vitro
下载PDF
导出
摘要 目的:制备载纳豆激酶(NK)的三甲基壳聚糖(TMC)纳米粒(TMC-NK-NPs),并研究其体外释放度。方法:合成季胺化度分别为15%、20%、25%的TMC(即TMC15、TMC20、TMC25),将其与NK自组装形成TMC-NK-NPs。测定TMC-NK-NPs的粒径、多分散系数(PDI)、Zeta电位,筛选TMC;观察并测定最优处方制备的TMC-NK-NPs的形态、包封率、载药量、4℃避光下30 d的稳定性、24 h内的体外累积释放度(Q)及NK活性。结果:采用TMC20所制TMC-NK-NPs的粒径较小[(161.0±4.8)nm],PDI最小(0.204),Zeta电位为(19.2±1.5)m V,呈球形或类球形;包封率为(45.4±1.51)%,载药量为(14.2±0.25)%;30 d内相对稳定;峰值Q_(12 h)为92.3%;NK活性在1 h时就达到最大(76.6%),但随着时间延长,活性降低。结论:成功制得形态圆整、包封率与载药量较高,且具有较好缓释作用的TMC-NK-NPs。 OBJECTIVE: To prepare nattokinase (NK)-loaded tfimethyl chitosan (TMC) nanoparticles (TMC-NK-NPs), and to study its release rate in vitro. METHODS: TMC with different degree of quatemization (15%, 20%, 25%) were synthetized, i.e. TMC15, TMC20, TMC25; those were combined with NK to form TMC-NK-NPs by self-assembly. The particle size, polydispersity index (PDI) and Zeta potential were determined and TCM was screened; the morphology, entrapment efficiency (EE) , drug-loading amount, 30 d stability at 4 ℃ and dark place, 24 h accumulative release rate in vitro (Q) and NK activity of TMC-NK-NPs by optimal formulation were observed and determined. RESULTS: Using TMC20, TMC-NK-NPs were smaller in particle size [(161.0± 4.8) nm], the lowest in PDI (0.204) ; the Zate potential was (19.2 ± 1.5) mV, spherical or spherical-like, EE was (45.4 ± 1.51)%, drug-loading amount was (14.2 ± 0.25)%, stable within 30 d, the peak Q12h was 92.3%. The maximum released activity of NK was 76.6% at 1 h, but then gradually decreased with time. CONCLUSIONS: TMC-NK-NPs are prepared successfully, round and complete with high EE and drug-loading amount, good sustained-release property.
出处 《中国药房》 CAS 北大核心 2016年第31期4403-4406,共4页 China Pharmacy
基金 国家自然科学基金资助项目(No.81373338)
关键词 三甲基壳聚糖 纳豆激酶 纳米粒 体外释放度 制备 Trimethyl chitosan Nattokinase Nanoparticles Release rate in vitro Preparation
  • 相关文献

参考文献12

  • 1Absar S,Choi S,Ahsan F,et al. Preparation and charac-terization of anionic oligopeptide-modified tissue plasmin-ogen activator for triggered delivery: an approach for lo-calized thrombolysis[J].Thromb Res,2013,131(3): e91.
  • 2Mattila OS, Sairanen T, Laakso E, et al. Cerebral amy-loid angiopathy related hemorrhage after stroke thrombol-ysis :case report and literature review[J].Neuropathology,2015,35(1):70.
  • 3Wei X,Luo M, Liu H. Preparation of the antithromboticand antimicrobial coating through layer-by-layer self-as-sembly of nattokinase-nanosilver complex and polyethyl-enimine[J].Colloids Surf B Biointerfaces,2014,doi:10.1016/j.colsurfb.2014.01.034.
  • 4Sawaengsak C, Mori Y,Yamanishi K, et al. Chitosan na-noparticle encapsulated hemagglutinin-split influenza vi-rus mucosal vaccine[J].AAPS Pharm Sci Tech,2014,15(2);317.
  • 5Bemkop-Schnxirch A, Dunnhaupt S. Chitosan-based drugdelivery systems [J].Eur J Pharm Biopharm ,2012,81(3):463.
  • 6郭晗,龚涛,黄园.黏液层对不同季铵化度的三甲基壳聚糖口服纳米粒的影响[J].中国药学杂志,2014,49(13):1146-1151. 被引量:2
  • 7Huang M,Vitharana SN,Peek LJ,et al. Polyelectrolytecomplexes stabilize and controllably release vascular en-dothelial growth factor[J], Biomacromolecules, 2007,8(5):1 607.
  • 8Cegnar M,Kerc J. Self-assembled polyelectrolyte nano-complexes of alginate, chitosan and ovalbumin[J].Acta2010,57(2):431.
  • 9Song L, Zhi ZL, Pickup JC. Nanolayer encapsulation ofinsulin-chitosan complexes improves efficiency of oral in-sulin delivery [J].Int J Nanomedicine, 2014, doi: 10.2147/IJN.S59075.
  • 10Sieval A, Thanou M, Verhoef J,et al. Preparation andNMR characterization of highly substituted n-trimethylchitosan chloride [J].Carbohydrate Polymers,1998,36(2):157.

二级参考文献35

  • 1吴雪松 ,王柏 ,赵茜 ,吴葆金 .双氯芬酸钠和醋氯芬酸溶液体外透皮吸收研究[J].中国药科大学学报,2004,35(4):311-314. 被引量:7
  • 2刘荣,闫锋,汪余疆,邓夕军,史迎昌.不同浓度的月桂氮酮对双氯芬酸钠凝胶剂透皮吸收的影响[J].华西药学杂志,2004,19(4):269-270. 被引量:11
  • 3何文,张冕,代文兵,吴燕.N-三甲基壳聚糖透皮吸收促进作用的初步研究[J].中国药学杂志,2006,41(7):519-522. 被引量:26
  • 4张冕,何文,李菁,代文兵.不同季铵化程度的N-三甲基壳聚糖透皮吸收促进作用的研究[J].中国药学杂志,2006,41(19):1475-1478. 被引量:17
  • 5Hamman JH,Stander M,Kotze AF. Effect of the degreee of quaterni- sation of N-trimethyl chitosan chloride on aborption enhancement : in vivo evaluation in rat epithelia[ J]. Int J Pharm ,2002,232:235-242.
  • 6Thanou M, Kotze AF, Scharringhausen T, et al. Effect of degree of quaternization of N-trimethyl chitosan chloride for enhanced transport of hydx-philic compounds across intestinal Caco-2 cell monolayers [ J]. J Control Release, 2000,64 : 15-25.
  • 7VAN DER MERWE S M, VERHOEF J C, VERHEIJDEN J H M, et al. Trimethylated chitosan as polymeric absorption enhan- cer for improved peroral delivery of peptide drugs [ J ] . Eur J Pharm Biopharm , 2004, 58 ( 2 ) : 225-235.
  • 8SNYMAN D, HAMMAN J H, KOTZE A F. Evaluation of the mucoadhesive properties of N-trimethyl chitosan chloride [ J ]. Drug Dev lnd Pharm, 2003, 29( 1 ) :61-69.
  • 9VAN DER MERWE S M, VERHOEF J C, KOTZE A F, et al. N-trimethyl chitosan chloride as absorption enhancer in oral peptide drug delivery. Development and characterization of minitablet and granule formulations [ J ]. Eur J Pharm Biopharm , 2004, 57 (1) :85-91.
  • 10SANDRI G, ROSSI S, BONFERONIMC, et al. Buccal penetration enhancement properties of N-trimethyl chitosan : Influence of quaternization degree on absorption of a high molecular weight molecule[J]. Int J Pharm , 2005, 297(1-2) :146-155.

共引文献9

同被引文献10

引证文献1

二级引证文献2

相关作者

内容加载中请稍等...

相关机构

内容加载中请稍等...

相关主题

内容加载中请稍等...

浏览历史

内容加载中请稍等...
;
使用帮助 返回顶部